Literature DB >> 27599701

Seroepidemiology of cytomegalovirus infections in Croatia.

Tatjana Vilibic-Cavlek1,2, Branko Kolaric3,4, Natasa Beader5,6, Izabela Vrtar7, Irena Tabain7, Gordana Mlinaric-Galinovic7,5.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) is endemic worldwide, with marked differences in the seroprevalence rates between countries. The aim of this study was to analyze the seroprevalence of CMV infections in Croatia.
METHODS: During a 3-year period (2013-2015) 2438 consecutive serum samples collected from Croatian residents were tested for the presence of CMV IgM and IgG antibodies using enzyme-linked immunoassay. The IgM/IgG positive samples were further tested for IgG avidity.
RESULTS: The overall seroprevalence rates for CMV IgG and IgM antibodies were 74.4 % and 4.3 %, respectively. The IgG seroprevalence showed significant differences between population groups: children/adolescents 54.6 %, general adult population 77.2 %, hemodialysis patients 91.4 % (p < 0.001). Seropositivity of CMV was strongly age-dependent with prevalences ranging from 53.0 % in children less than 10 years old to 93.8 % in persons above 60 years (p < 0.001). There was no difference in the prevalence rate between women with normal pregnancy and women with poor obstetric history. Gender and place of residence were not associated with CMV seropositivity. Using IgG avidity, current/recent primary CMV infection was confirmed by a low/borderline avidity index (AI) in 46.7 % participants, while in 53.3 % a high AI indicated CMV reactivation or reinfection. Primary infections were detected mainly in children and adolescents (83.2 % and 70.5 %, respectively), while reactivation/reinfection was common in persons older than 40 (77.0-100 %). Reactivation/reinfection was most commonly detected in hemodialysis patients (92.3 %). Logistic regression showed that older age and being on hemodialysis were significant predictors of CMV seropositivity.
CONCLUSION: Infections with CMV are widespread in the Croatian population. Older age and being on hemodialysis appear to be the main risk factors for CMV infection.

Entities:  

Keywords:  Croatia; Cytomegalovirus; Epidemiology; Seroprevalence

Mesh:

Substances:

Year:  2016        PMID: 27599701     DOI: 10.1007/s00508-016-1069-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  38 in total

1.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

2.  [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].

Authors:  Senay Ataman; Dilek Colak; Filiz Günseren; Yeşim Senol; Taner Colak; Mehmet R Aktekin; Meral Gültekin
Journal:  Mikrobiyol Bul       Date:  2007-10       Impact factor: 0.622

3.  Seroprevalence of TORCH infections in women of childbearing age in Croatia.

Authors:  Tatjana Vilibic-Cavlek; Suncanica Ljubin-Sternak; Mirela Ban; Branko Kolaric; Mario Sviben; Gordana Mlinaric-Galinovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-17

Review 4.  [Diagnostic approach and therapy for cytomegalovirus (CMV) infection following allogeneic stem cell transplantation].

Authors:  Natasa Beader; Smilja Kalenić; Boris Labar
Journal:  Lijec Vjesn       Date:  2011 Nov-Dec

5.  [Cytomegalovirus infection in Omsk region].

Authors:  T I Dolgikh; V V Dalmatov; N S Zapariĭ; T V Kadtsyna
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  2008 May-Jun

6.  Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care.

Authors:  Gini G C van Rijckevorsel; Lian P M J Bovée; Marjolein Damen; Gerard J B Sonder; Maarten F Schim van der Loeff; Anneke van den Hoek
Journal:  BMC Public Health       Date:  2012-06-22       Impact factor: 3.295

7.  Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study.

Authors:  Lucy Pembrey; Pauline Raynor; Paul Griffiths; Shelley Chaytor; John Wright; Andrew J Hall
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

8.  Prevalence and dynamics of cytomegalovirus infection among patients undergoing chronic hemodialysis.

Authors:  T Vilibic-Cavlek; B Kolaric; S Ljubin-Sternak; M Kos; B Kaic; G Mlinaric-Galinovic
Journal:  Indian J Nephrol       Date:  2015 Mar-Apr

9.  Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.

Authors:  Andrew A Adjei; Henry B Armah; Foster Gbagbo; Isaac Boamah; Clement Adu-Gyamfi; Isaac Asare
Journal:  BMC Infect Dis       Date:  2008-08-18       Impact factor: 3.090

10.  Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.

Authors:  Dieynaba S N'Diaye; Yazdan Yazdanpanah; Anne Krivine; Thibaut Andrieu; Flore Rozenberg; Olivier Picone; Vassilis Tsatsaris; François Goffinet; Odile Launay
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more
  5 in total

Review 1.  Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation.

Authors:  Jan Styczynski
Journal:  Infect Dis Ther       Date:  2017-12-04

2.  The convergent epidemiology of tuberculosis and human cytomegalovirus infection.

Authors:  Frank Cobelens; Nico Nagelkerke; Helen Fletcher
Journal:  F1000Res       Date:  2018-03-06

3.  A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.

Authors:  Witold Lewandowski; Carla Talarico; Karen Fowler; Jacek Mucha; Monika Neumann; Magdalena Kaczanowska; Maciej Grys; Elvira Schmidt; Andrew Natenshon; Philip O Buck; John Diaz-Decaro
Journal:  BMC Public Health       Date:  2022-09-01       Impact factor: 4.135

Review 4.  Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.

Authors:  Shahzma Merani; Graham Pawelec; George A Kuchel; Janet E McElhaney
Journal:  Front Immunol       Date:  2017-07-17       Impact factor: 7.561

5.  Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.

Authors:  Raskit Lachmann; Anna Loenenbach; Tim Waterboer; Nicole Brenner; Michael Pawlita; Angelika Michel; Michael Thamm; Christina Poethko-Müller; Ole Wichmann; Miriam Wiese-Posselt
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.